Hormone Resistant Prostate Cancer Completed Phase 1 Trials for Rasdegafusp alfa (DB15185)

Also known as: Hormone-Resistant Prostate Cancer

IndicationStatusPhase
DBCOND0038482 (Hormone Resistant Prostate Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01522820Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsTreatment